Skip to main content
Clinical Trials/CTRI/2023/06/054193
CTRI/2023/06/054193
Recruiting
未知

A prospective, observational, comparative study on effects of newer P2Y12 receptor antagonists on inflammatory markers, in diabetic patients undergoing percutaneous coronary intervention - Nil

Dr Ankita Panigrahy0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E08-E13- Diabetes mellitusHealth Condition 2: I20-I25- Ischemic heart diseases
Sponsor
Dr Ankita Panigrahy
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Ankita Panigrahy

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients aged between 35 \- 70 years of either gender.
  • 2\.Diabetic patients , with either stable angina, unstable angina or NSTEMI, with the above mentioned drug therapy and planned for PCI.
  • 3\.Patients with Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 after PCI.

Exclusion Criteria

  • 1\.Patients posted for Coronary bypass surgery.
  • 2\.Patients with uncontrolled diabetes
  • 3\.History of stroke or transient ischemic attack or intracranial bleeding at any time
  • 4\.Patients who had previous cardiac intervention
  • 5\.Patients with cardiogenic shock or hypovolemia
  • 6\.Left Ventricular Ejection Fraction (LVEF) \< 30%
  • 7\.Patients with ST segment elevated myocardial infarction
  • 8\.Patients with chronic kidney disease stage 3 and beyond
  • 9\.Patients requiring reintervention in the study period
  • 10\.Need for chronic anti coagulation therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials